2026-07-16 12:03
Biohaven Stock Outlook 2026: Pipeline, Spin-Off, IRA, Spheramine, Insiders, Cash, Patents & Gepant Competition【biohaven pharmaceuticals stock】
2026-07-16 12:03
Biohaven Stock Analysis: Risks, Debt, Ownership, HERO Trial, NURTEC Coverage, Tax Benefits & VYDURA Global Expansion【biohaven pharmaceuticals stock】
2026-07-16 12:03
Biohaven Q4 2024–2025 Catalysts, Buybacks, R&D, Analyst Ratings & NBI Performance【biohaven pharmaceuticals stock】
2026-07-16 12:03
Biohaven Financial Health: Short Interest, Debt, Equity Dilution, and NURTEC Gross Margin Analysis【biohaven pharmaceuticals stock】
2026-07-16 12:03
30 Strategic Biohaven (BHVN) Questions: VYDURA FDA Impact, EV/S Valuation vs AbbVie Teva Jazz【biohaven pharmaceuticals stock】
2026-07-16 11:33
Biohaven’s Strategic Evolution (2019–2023): CGRP Licensing, Cash Runway, SEC Disclosures, Workforce, and Vyepti Reimbursement【biohaven pharma stock】
2026-07-16 11:33
Kita, Margen, at Datos Tungkol sa Rimegepant ng Biohaven (2020–2022)【biohaven pharma stock】
2026-07-16 11:33
बायोहैवन का राजस्व, मार्जिन और राइमेगेपैंट के आँकड़े (2020–2022)【biohaven pharma stock】
2026-07-16 11:33
Biohaven’s Revenue, Margins, and Rimegepant Data (2020–2022)【biohaven pharma stock】
2026-07-16 11:33
बायोहैवन फार्मास्यूटिकल्स पर 30 मुख्य प्रश्न: न्यूरटेक ओडीटी से लेकर फाइजर अधिग्रहण तक (2017–2023)【biohaven pharma stock】
最新消息
2026-09-27 06:32
2026-09-27 06:32
2026-09-27 06:32